Minimal clinically important difference for the 6-min walk test: literature review and application to Morquio A syndrome
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Minimal clinically important difference for the 6-min walk test: literature review and application to Morquio A syndrome
Authors
Keywords
Enzyme replacement therapy, Morquio A syndrome, Mucopolysaccharidosis IVA, Endurance, Six-minute walk test, Minimal clinically important difference, MPS IVA
Journal
Orphanet Journal of Rare Diseases
Volume 12, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-04-26
DOI
10.1186/s13023-017-0633-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of long-term elosulfase alfa treatment on respiratory function in patients with Morquio A syndrome
- (2016) Christian J. Hendriksz et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Long-term endurance and safety of elosulfase alfa enzyme replacement therapy in patients with Morquio A syndrome
- (2016) Christian J. Hendriksz et al. MOLECULAR GENETICS AND METABOLISM
- Multi-domain impact of elosulfase alfa in Morquio A syndrome in the pivotal phase III trial
- (2015) Christian J. Hendriksz et al. MOLECULAR GENETICS AND METABOLISM
- Longitudinal analysis of endurance and respiratory function from a natural history study of Morquio A syndrome
- (2015) Paul R. Harmatz et al. MOLECULAR GENETICS AND METABOLISM
- International guidelines for the management and treatment of Morquio A syndrome
- (2014) Christian J. Hendriksz et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease
- (2014) Sally J. Singh et al. EUROPEAN RESPIRATORY JOURNAL
- Minimal Clinically Important Difference
- (2014) Anna E. McGlothlin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study
- (2014) Christian J. Hendriksz et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Burden of disease in patients with Morquio A syndrome: results from an international patient-reported outcomes survey
- (2014) Christian J Hendriksz et al. Orphanet Journal of Rare Diseases
- Minimal important difference in field walking tests in non-cystic fibrosis bronchiectasis following exercise training
- (2014) A.L. Lee et al. RESPIRATORY MEDICINE
- Incremental cost per quality-adjusted life year gained? The need for alternative methods to evaluate medical interventions for ultra-rare disorders
- (2014) Michael Schlander et al. Journal of Comparative Effectiveness Research
- Prognostic significance of six-minute walk test in non-group 1 pulmonary hypertension
- (2013) Rafael Golpe et al. HEART & LUNG
- The Morquio A Clinical Assessment Program: Baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjects
- (2013) Paul Harmatz et al. MOLECULAR GENETICS AND METABOLISM
- Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA
- (2013) C.J. Hendriksz et al. MOLECULAR GENETICS AND METABOLISM
- The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: Reliability, concurrent validity, and minimal clinically important differences from a multicenter study
- (2013) Craig M. McDonald et al. MUSCLE & NERVE
- The clinical relevance of outcomes used in late-onset Pompe disease: can we do better?
- (2013) Robin Lachmann et al. Orphanet Journal of Rare Diseases
- Prognostic value of six minute walk test in cystic fibrosis adults
- (2013) Clémence Martin et al. RESPIRATORY MEDICINE
- Reference values for the 6-minute walk test in healthy children and adolescents in Switzerland
- (2013) Silvia Ulrich et al. BMC Pulmonary Medicine
- The minimal clinically important difference of six-minute walk in Asian older adults
- (2013) Boon Chong Kwok et al. BMC Geriatrics
- The Minimal Important Difference in the 6-Minute Walk Test for Patients with Pulmonary Arterial Hypertension
- (2012) Stephen C. Mathai et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Six-Minute-Walk Test in Chronic Obstructive Pulmonary Disease
- (2012) Michael I. Polkey et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Prognostic value of the six-minute walk test in end-stage renal disease life expectancy: a prospective cohort study
- (2012) LM Kohl et al. Clinics
- Determining the Minimal Clinically Important Difference for the Six-Minute Walk Test and the 200-Meter Fast-Walk Test During Cardiac Rehabilitation Program in Coronary Artery Disease Patients After Acute Coronary Syndrome
- (2011) Vincent Gremeaux et al. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
- Six-Minute-Walk Test in Idiopathic Pulmonary Fibrosis
- (2010) Roland M. du Bois et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Updating the Minimal Important Difference for Six-Minute Walk Distance in Patients With Chronic Obstructive Pulmonary Disease
- (2010) Anne E. Holland et al. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
- The minimal important difference of exercise tests in severe COPD
- (2010) M. A. Puhan et al. EUROPEAN RESPIRATORY JOURNAL
- Six-minute walk distance predicts mortality in liver transplant candidates
- (2010) Elizabeth J. Carey et al. LIVER TRANSPLANTATION
- Deficiency in N-acetylgalactosamine-6-sulfate sulfatase results in collagen perturbations in cartilage of Morquio syndrome A patients
- (2009) Ruud A. Bank et al. MOLECULAR GENETICS AND METABOLISM
- Small changes in six-minute walk distance are important in diffuse parenchymal lung disease
- (2009) Anne E. Holland et al. RESPIRATORY MEDICINE
- The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference
- (2009) J. J. Swigris et al. THORAX
- Distance and Oxygen Desaturation During the 6-min Walk Test as Predictors of Long-term Mortality in Patients With COPD
- (2008) Ciro Casanova et al. CHEST
- Estimating a Minimally Important Difference in Pulmonary Arterial Hypertension Following Treatment With Sildenafil
- (2008) Claire Gilbert et al. CHEST
- Interpretation of treatment changes in 6-minute walk distance in patients with COPD
- (2008) M. A. Puhan et al. EUROPEAN RESPIRATORY JOURNAL
- Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase
- (2008) Paul Harmatz et al. MOLECULAR GENETICS AND METABOLISM
- The 6-minute walk test: normal values for children of 4-11 years of age
- (2007) A E Lammers et al. ARCHIVES OF DISEASE IN CHILDHOOD
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now